VISIOMED GROUP EO 001

Research VISIOMED GROUP EO 001 (7V91) on Bullrun: market cap EUR 43.89M, P/E 14.3. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 43.89M; P/E is 14.3.

Peer valuation comparison

Latest P/E is 14.34x versus a Healthcare sector median of 24.46x (41.4% below).

Latest P/E is 14.34x versus a France median of 15.25x (6.0% below).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025EUR 22.17MEUR 2.28MEUR 3.90M44.2%0.01EUR 5.25MEUR 5.37MEUR 27.61M
FY2024EUR 17.26MEUR 1.41MEUR 166.00K47.8%0EUR 3.31MEUR 5.88MEUR 27.95M
FY2023EUR 13.71MEUR 902.00K-EUR 1.50M46.0%0EUR 2.97MEUR 7.93MEUR 24.10M
FY2022EUR 14.45M-EUR 5.28M-EUR 7.26M22.2%-0.02EUR 2.36MEUR 5.62MEUR 24.27M
FY2021EUR 7.17M-EUR 4.46M-EUR 6.70M-10.0%-0.03EUR 6.57MEUR 4.95MEUR 14.08M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-27EUR 43.89M14.3n/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About VISIOMED GROUP EO 001

Klea Holding SA, together with its subsidiaries, develops health technologies and services in France, the United Arab Emirates, and Saudi Arabia. It operates digitalized medical centers that provide administrative screenings for residency and work visas, preventive health check-ups, and medical fitness tests under the Smart Salem brand. In addition, the company engages in the production of pharmaceuticals. The company was formerly known as Visiomed Group SA and changed its name to Klea Holding SA in June 2024.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is VISIOMED GROUP EO 001's market cap?

VISIOMED GROUP EO 001's market capitalization is EUR 43.89M.

What is VISIOMED GROUP EO 001's P/E ratio?

VISIOMED GROUP EO 001's price-to-earnings (P/E) ratio is 14.3.

What does VISIOMED GROUP EO 001 do?

Klea Holding SA, together with its subsidiaries, develops health technologies and services in France, the United Arab Emirates, and Saudi Arabia. It operates digitalized medical centers that provide administrative screenings for residency and work visas, preventive health check-ups, and medical fitness tests under the Smart Salem brand. In addition, the company engages in the production of pharmaceuticals. The company was formerly known as Visiomed Group SA and changed its name to Klea Holding SA in June 2024. Klea Holding SA was founded in 2007 and is headquartered in Paris, France.